At their annual meeting in Suzhou on 12 November 2019, EPO President António Campinos and the Commissioner of the China National Intellectual Property Administration (CNIPA), Shen Changyu, agreed to enhance their bilateral co-operation in the framework of the Patent Cooperation Treaty (PCT). The aim is to give patent applicants filing an international patent application in English at the CNIPA as Receiving Office the choice to opt for the EPO as their International Searching Authority (ISA).
It is expected that this new option will be offered in the course of next year, and be implemented as a two-year pilot programme.
CNIPA Commissioner Dr. Shen Changyu said: “The EPO and CNIPA are comprehensive strategic partners. For more than 30 years, the two offices have maintained a long-term close co-operative relationship. The fruitful cooperation results greatly benefited users and the public both in Europe and China. The two offices reached consensus on the designation of EPO as an ISA of the PCT international patent application in English filed at the CNIPA as Receiving Office. It will further benefit PCT applicants in China and even around the world. It is also a solid …Read More
The “X Annual Intellectual Property Conference of China” held in Hangzhou, eastern Zhejiang Province, brought important developments in intellectual property for the Asian global power. The director of the ¨National Copyright Administration of China¨, Shen Changyu, said last September 2nd, that the country is working to implement a strict system of intellectual property protection, in order to continue with the development of a satisfactory innovation and business environment in the territory.
Among the planned measures, in the case of trademarks, the aforementioned director explained that China will apply a very strict new punitive system of compensation to fight trademark violations and it will intensify efforts to deal with malicious trademark registrations. On the other hand, in the case of patents, a patent law review is planned and, also, the development of a compensation system for the protection of drug patents. Moreover, the country will also extend the period of protection of designs, and improve the quality and efficiency in intellectual property review.
Within the global context where China is waging a commercial battle against the United States, these changes to be implemented will have consequences not only in the Asian country, …Read More